Except for that research reveals that mutation of KRAS is required in the initiation and maintenance of pancreatic cancer [22], some results further imply that the KRAS overexpression is also valuable to be uncovered for tumorigenesis. This evidence concerns the gene KRAS and pancreatic neoplasm.